 SALT LAKE CITY , June 15, 2022 PRNewswire -- Co-Diagnostics, Inc. Nasdaq: CODX the Company or Co-Dx,, a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Dwight Egan, CEO, Brian Brown, CFO, and Andrew Benson, Head of Investor Relations, will present and host one-on-one meetings with investors at the Sidoti Summer Small Cap Virtual Investor Conference June 15-16, 2022. The presentation will begin at 3:15 p.m. 